Get the latest news, inspiring stories, upcoming events, and valuable support services delivered straight to your inbox.
ALL NEWS
Filter by type

Disappointing results from phase 2 clinical trial for Duchenne muscular dystrophy
December 19, 2024

Phase 2 clinical trial, CANYON, shows potential at reducing muscle damage in Becker muscular dystrophy
December 18, 2024

The global search for new treatments: highlights from the Annual Congress of the World Muscle Society
November 22, 2024

Targeted gene-silencing: a new solution for Collagen VI muscular dystrophy
November 11, 2024

Development of Duchenne muscular dystrophy gene therapy stopped
November 7, 2024

Our 2025 research grant round is now open
October 15, 2024

Phase 3 clinical trial, the SAPPHIRE study, shows promising results in treating SMA
October 8, 2024

Project secures funding to continue genotype phenotype correlation of the DMD and BMD brain
September 18, 2024

We’ve awarded over £1m to the LifeArc Centre to Treat Mitochondrial Disorders
September 17, 2024

Disappointing results from phase 3 FSHD clinical trial
September 12, 2024

Celebrating 20 years: NorthStar a ‘shining light’ for people living with Duchenne muscular dystrophy
September 7, 2024

We’re investing £1.7m into new research
August 29, 2024